Search results
Results from the WOW.Com Content Network
BrainHQ rewires the brain so you can think faster, focus better, and remember more. And that helps people feel happier, healthier, and more in control. Sign up now!
It makes people feel happier, healthier, and more in control of their lives. While most brain games lack any proof of effectiveness, BrainHQ’s benefits have been shown in hundreds of clinical ...
Social media also plays a role, with many people on these platforms encouraging others to pursue an autism diagnosis or even self-diagnose. "I think this has driven more people to seek a possible ...
In the UK the National Autism Plan for Children recommends at most 30 weeks from first concern to completed diagnosis and assessment, though few cases are handled that quickly in practice. [6] Lack of access to appropriate medical care, broadening diagnostic criteria and increased awareness surrounding ASD in recent years has resulted in an ...
This poses a challenge to psychiatrists in identifying undiagnosed adults who may have autism. [2] Adults are being referred or self referred for diagnosis with increasing frequency, making this a useful clinical tool. [3] A score of 64 or more has been shown to be consistent and support a clinical diagnosis, but in the case the clinical ...
The autism-spectrum quotient (AQ) is a questionnaire published in 2001 by Simon Baron-Cohen and his colleagues at the Autism Research Centre in Cambridge, UK.Consisting of fifty questions, it aims to investigate whether adults of average intelligence (defined as an IQ of 80 or higher by the questionnaire) have symptoms of autism spectrum conditions. [1]
It takes a lot of brainpower to create BrainHQ’s brain training program.And much of that belongs to one man: Michael Merzenich, Ph.D., a professor emeritus at University of California San ...
Posit Science Corporation is an American company providing brain training software and services. [1] [2]Originally known as Neuroscience Solutions Corporation, the company was founded in 2002 by neuroscientists Michael Merzenich and Henry Mahncke, who originally intended to help people with schizophrenia. [3]